Keywords: fda, extends, review, frova, snda, usa-based, drugmaker

FDA extends review of Frova sNDA

Article | 26 March 2007

Print This

USA-based drugmaker Endo Pharmaceutical Holdings and UK drug developer Vernalis have been informed by the US Food and Drug Administration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in